Alyeska Investment Group, L.P. Standard Biotools Inc. Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.94 - $7.09 $1.46 Million - $2.62 Million	-370,103 Reduced 41.77%	515,964 $2.33 Million
Q4 2020 Feb 16, 2021	BUY	$5.45 - $8.65 $1.76 Million - $2.8 Million	323,567 Added 57.52%	886,067 $5.32 Million
Q3 2020 Nov 16, 2020	BUY	$4.34 - $11.43 $958,684 - $2.52 Million	220,895 Added 64.66%	562,500 $4.18 Million
Q2 2020 Aug 14, 2020	SELL	$1.85 - $5.29 $1.44 Million - $4.13 Million	-780,461 Reduced 69.56%	341,605 $1.37 Million
Q4 2019 Feb 14, 2020	BUY	$2.3 - $5.12 $2.58 Million - $5.74 Million	1,122,066 New	1,122,066 $3.9 Million

143

276M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $127M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.